(Date:12/5/2008)... RICHMOND HILL, ON, Dec. 5 /PRNewswire/ - Norgine,...pany, has today announced that it has granted Medi...P(R) in Canada. , MOVIPREP is a novel patent-pr...ansing prior to colonoscopy and other situations w...keted by Norgine in Europe and in the USA by its p...
(Date:12/5/2008)... BELLUS Health Receives NASDAQ Deficiency Notice R...--------------------------------------------------...ll/ - BELLUS Health Inc. (NASDAQ: BLUS ; TSX: BL...nt fluctuations in world capital markets, the Comp...SDAQ Capital Market, while continuing to maintain ...
(Date:12/5/2008)..., Dr. Alan Greene from th...ar milestone of eating only organic food. It,s the...tified 100% organic. , Da... animals can be certified organic by the Departmen...n and author Dr. Alan Greene, why not people?, , ,...
(Date:12/4/2008)..., Early detection of lung disease in cystic fibro...fants, may be the key to controlling the progressi...w research shows that contrary to previous scienti...s can begin as early as infancy even though lung f...e might be able to stop some of the lung function ...
Breaking Medicine News(10 mins):Health News:Medical Futures partners with Norgine for MOVIPREP(R) in Canada 2Health News:BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capital Market 2Health News:BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capital Market 3Health News:Dr. Alan Greene: The Organic Man -- Renowned Pediatrician Marks Third Anniversary of Organic-Only Diet 2Health News:Dr. Alan Greene: The Organic Man -- Renowned Pediatrician Marks Third Anniversary of Organic-Only Diet 3Health News:Intervention in infants with cystic fibrosis key to slowing progression 2Health News:Intervention in infants with cystic fibrosis key to slowing progression 3...e WHO has issue a checklist for doctors and nurse ...s. Basic mistakes like not washing hands by the h...arters. The WHOs 9 solution is meant to improve p...essen the number of health care related accidents ...
...e Delhi High Court Wednesday held that the misuse ...taff would be viewed seriously, stressing that th...ision bench of Justice T.S. Thakur and Justice S.N... of the hospitals of both state and central govern...
...California-based Keralite doctor has bagged this y...the National Ethnic Coalition of Organisations (NE... award May 12, said he was "really delighted". "Th...o be a boost for all my future endeavours," Eapen ...
...ldiers returning from Iraq who have migraine heada...mptoms of post-traumatic stress, depression or anx...ording to research. The study involved 3,621 Unite...en a health screening questionnaire within 90 days...
Other Medicine News:Health News:UN Agencys Checklist on Health Care Error 2Health News:Migraines may Be a Symptom of Other Problems for Iraq Soldiers 2(Date:12/3/2008).... Jude treatment alleviates long-term anemia and o...plications , , MEMPHIS, Tenn., Dec. 3 /PRN...nsert a corrective gene into mouse blood cells, sc...have alleviated sickle cell disease pathology. In ...ted mice showed essentially no difference from nor...
(Date:12/3/2008)..., Del., Dec. 3 Isogen, a contract ...erile filling, announced it has retained a,strate... to meet the global,biopharma demand for Isogen,s...d a successful first round series of capital,inve...acility in Q1 2009 to,deliver on the previously u...
(Date:12/3/2008)...EGO, Dec. 3 Vical Incorp...sive, binding letter of intent with EIP,Eczacibas...g of the company,s,Allovectin-7(R) immunotherapeu...epublic of Northern Cyprus. EIP has agreed to obta...ritory and to pay Vical upfront and milestone paym...
(Date:12/2/2008)...DGE, Mass., Dec. 2 Biopu...that the U.S. Naval Medical Research Center,(NMRC...n (FDA) a revised,investigational new drug (IND) ...mpany,s oxygen therapeutic Hemopure(R) [hemoglobin...ttlefield treatment of trauma patients. The study ...
Breaking Medicine Technology:Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Pfizer Partners with REvolution Computing to Improve Medicine Production Pipeline 17917 1Pfizer Partners with REvolution Computing to Improve Medicine Production Pipeline 17917 2Pfizer Partners with REvolution Computing to Improve Medicine Production Pipeline 17917 3Bristol Myers Squibb Issues 241 6 Billion of Senior Notes 4935 1Bristol Myers Squibb Issues 241 6 Billion of Senior Notes 4935 2Insmed Provides Update on Follow On Biologics and IPLEX 28TM 29 Programs 1920 1Insmed Provides Update on Follow On Biologics and IPLEX 28TM 29 Programs 1920 2Insmed Provides Update on Follow On Biologics and IPLEX 28TM 29 Programs 1920 3Insmed Provides Update on Follow On Biologics and IPLEX 28TM 29 Programs 1920 4Insmed Provides Update on Follow On Biologics and IPLEX 28TM 29 Programs 1920 51 in 4 U S Toddlers Improperly Vaccinated 17913 11 in 4 U S Toddlers Improperly Vaccinated 17913 21 in 4 U S Toddlers Improperly Vaccinated 17913 3...LLE, Md., June 08, 2007 /PRNewswire-FirstCall/ -- .... Tom Roth, Director of,the Henry Ford Sleep Disor...ver an oral presentation on recent Phase III clini...latonin (MT1/MT2),receptor agonist, at SLEEP 2007,...ional Sleep Societies, (APSS). , The Vanda present...
...istically significant reduction in sedation during...ine , * Statistically significant reduction in nau...orphine , Cambridge, UK, 8th June 2007 - CeNeS Pha...iopharmaceutical company, announces,additional dat...rial (M6G022) of M6G (morphine-6-glucuronide) in o...
Other Medicine Technology:Vanda Pharmaceuticals To Present Data on VEC-162 at SLEEP 2007, the,Annual Meeting of the Associated Professional Sleep Societies 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7...ingle-piece posterior chamber lenses are optical i...ne lens in the visual correction of aphakia in pat...on consists of a high refractive index soft acryli...supporting haptics of the ACRYSOF soft acrylic IOL...
...PMMA Posterior Chamber Intraocular Lenses are inte...isual correction of aphakia in patients 60 years o...emoved by extracapsular extraction methods. These ...lcus or capsular bag. Lenses with an overall diame...
Single-Piece PMMA Intraocular Lenses.
An injectable IOL, single-use injector for the IOL and post-op protective eye-shield all packaged in one handy, ready-to-use system pack.
Medicine Products: